Cardiovascular implant, method and device for its production, and its provision for surgery

• US 20050143810A1
• Filed: 10/22/2004
• Published: 06/30/2005
• Est. Priority Date: 10/24/2003
• Status: Abandoned Application

• Current Assignee: Bruno M. Meiser, Bruno Reichart, Deutsche Institute Fur Textil-Und Faserforschung Stuttgart Stiftung Des Oeffentlichen Rechts, Helmut Gulbins
• Original Assignee: Bruno M. Meiser, Bruno Reichart, Deutsche Institute Fur Textil-Und Faserforschung Stuttgart Stiftung Des Oeffentlichen Rechts, Helmut Gulbins
• Inventors: Planck, Heinrich, Doser, Michael, Gulbins, Helmut, Meiser, Bruno, Reichart, Bruno, Kottler, Reinhard, Dauner, Martin
• Application Number:
  US10/970,831
• Publication Number:
  US 20050143810A1
• Time in Patent Office: Days
• US Class Current: 623/2.120
• CPC Class Codes: A61F 2/06 Blood vessels
• CPC Class Codes: A61F 2/2412 with soft flexible valve members, e.g. tissue valves shaped like natural valves check valves with flexible valve members in general F16K15/14
• CPC Class Codes: A61F 2/2418 Scaffolds therefor, e.g. support stents
• CPC Class Codes: C12M 25/02 Membranes; Filters filters or filtration in general B01D24/00-B01D41/00
• CPC Class Codes: C12M 27/14 Rotation or movement of the cells support, e.g. rotated hollow fibers

Abstract

A cardiovascular implant for use in surgery, in particular a heart valve with flaps, made substantially of biocompatible synthetic polymer material in the form of a three-dimensional structure, wherein the polymer material is substantially nonabsorbable under physiological conditions, and the implant, at least on part of its surface, is formed as a microporous nonwoven from microfibers of the polymer material, which permit colonization with cells.

Claims

1-26. -26. (canceled)

27. A cardiovascular implant for use in surgery made substantially of biocompatible synthetic polymer material in the form of a three-dimensional structure, wherein the polymer material is substantially nonabsorbable under physiological conditions, and the implant, at least on part of its surface, is formed as a microporous nonwoven from microfibers of the polymer material, which permit colonization with cells.

28. The implant as claimed in claim 27, wherein the implant is a heart valve with flaps.

29. The implant as claimed in claim 27, wherein the nonwoven has a thickness of 10 to 500 μ

m.

30. The implant as claimed in claim 29, wherein the nonwoven has a thickness of 30 to 70 μ

m.

31. The implant as claimed in claim 27, wherein the microfibers have a thickness of 0.1 to 10 μ

m.

32. The implant as claimed in claim 27, wherein the nonwoven has a pore size in the range of 0.1 to 20 μ

m.

33. The implant as claimed in claim 32, wherein the pore size is in the range of 1 to 8 μ

m.

34. The implant as claimed in claim 28, in the form of a heart valve prosthesis comprising a tubular portion as a stump of a cardiac blood vessel which is designed to be sutured onto an end piece of a natural blood vessel, three flaps which form a heart valve being arranged movably relative to one another on the stump and interacting with one another as a valve so as to open and close upon flow of blood.

35. The implant as claimed in claim 34, wherein the cardiac blood vessel is an aortic stump.

36. The implant as claimed in claim 28, wherein the heart valve flaps are made from a planar nonwoven.

37. The implant as claimed in claim 28, wherein the heart valve flaps are arched.

38. The implant as claimed in claim 34, wherein the implant has a wall thickness of 1 to 3 mm in the area of the vessel portion.

39. The implant as claimed in claim 28, wherein the heart valve flaps are produced as separate parts and are secured on the tubular portion of the prosthesis.

40. The implant as claimed in claim 39, wherein the parts are secured by one or more of adhesively bonded and melted.

41. The implant as claimed in claim 28, wherein the heart valve prosthesis is made in one piece with the flaps.

42. The implant as claimed in claim 41, wherein the tubular portion of the heart valve prosthesis is made in one piece with the flaps.

43. The implant as claimed in claim 34, wherein the heart valve flaps and the tubular portion have a different structure.

44. The implant as claimed in claim 34, wherein the heart valve flaps and the tubular portion are made from different materials.

45. The implant as claimed in claim 34, wherein the heart valve prosthesis is provided with a reinforcement.

46. The implant as claimed in claim 45, wherein the reinforcement is provided in the tubular portion of the heart valve prosthesis.

47. The implant as claimed in claim 49, wherein the reinforcement is in the form of a textile construction.

48. The implant as claimed in claim 27, wherein the implant is produced at least partially by a spray-bonding technique.

49. The implant as claimed in claim 27, wherein the implant is desgined for colonization with living cells.

50. The implant as claimed in claim 49, wherein the cells are human cells.

51. The implant as claimed in claim 50, wherein the implant is colonized with human cells at least partially.

52. The implant as claimed in claim 49, wherein the implant is colonized with living cells in several layers.

53. The implant as claimed in claim 49, wherein colonizing cells cover the surface, directed toward the blood, as a flat cell sheet.

54. The implant as claimed in claim 49, wherein colonizing cells are chosen from the group of fibroblasts, smooth muscle cells and endothelial cells.

55. The implant as claimed in claim 54, wherein the endothelial cells are colonized on the implant on a cell layer containing one or more of fibroblasts and smooth muscle cells.

56. The implant as claimed in claim 53, wherein the colonizing cell sheet has a high shear strength.

62. Provision of the implant as claimed in claim 27 as a vascular prosthesis in cardiovascular surgery.

63. Provision of the implant as claimed in claim 27 as a heart valve prosthesis in cardiac surgery.

57. A method for producing a biohybrid implant made substantially of biocompatible synthetic polymer material in the form of a three-dimensional structure with a nonwoven-type surface, wherein a preform of the implant made of synthetic polymer material is colonized with human cells, initially with one or more of fibroblasts and smooth muscle cells, then colonized with endothelial cells in a surface cell layer.

58. The method as claimed in claim 57, wherein colonization of endothelial cells is performed after a rest phase for anchoring of the first cell layer.

59. The method as claimed in claim 57, wherein endothelial cells, fibroblasts and smooth muscle cells are obtained from explanted sections of the great saphenous vein of the patient to be treated and are cultivated in specific cell media using human serum from the patient.

60. The method as claimed in claim 57, wherein the heart valve, during and/or after its production, is connected to tubular connection pieces which are used for connection to the heart and to the aortic arch.

61. A device for producing a biohybrid implant, carrying out the method as claimed in claim 57, comprising an incubator which is designed for cell colonization of a preform of a surgical implant made of synthetic polymer material and which receives the cell medium, rotatable about at least one axis, and a support which can be placed in it for receiving and fixing the implant to be coated with cells.